Citation Impact
Citing Papers
Loss of cryptochrome reduces cancer risk in p53 mutant mice
2009 StandoutNobel
Management of Helicobacter pylori infection—the Maastricht IV/ Florence Consensus Report
2012 Standout
Deregulated expression of the PER1 , PER2 and PER3 genes in breast cancers
2005
From circadian clock gene expression to pathologies
2007
A split, conditionally active mimetic of IL-2 reduces the toxicity of systemic cytokine therapy
2022 StandoutNobel
Cryptochrome, Circadian Cycle, Cell Cycle Checkpoints, and Cancer
2005 StandoutNobel
Psychological Stress and Disease
2007 Standout
Inflammation and Its Discontents: The Role of Cytokines in the Pathophysiology of Major Depression
2009 Standout
Are Circadian Rhythms the Code of Hypothalamic-Immune Communication? Insights from Natural Killer Cells
2007
The role and validity of actigraphy in sleep medicine: An update
2011 Standout
Perspectives on cancer therapy-induced mucosal injury
2004 Standout
Neurocognitive Consequences of Sleep Deprivation
2009 Standout
Disruption of Circadian Coordination and Malignant Growth
2006
Prognostic Factors Predictive of Response and Survival to a Modified FOLFOX Regimen: Importance of an Increased Neutrophil Count
2006
Self-Reported and Measured Sleep Duration
2008 Standout
A cytokine-mediated link between innate immunity, inflammation, and cancer
2007 Standout
Temporal interrelationships among fatigue, circadian rhythm and depression in breast cancer patients undergoing chemotherapy treatment
2001
MASCC/ISOO clinical practice guidelines for the management of mucositis secondary to cancer therapy
2014 Standout
Immunopathogenesis and therapy of cutaneous T cell lymphoma
2005
REST/ACTIVITY RHYTHMS AND MORTALITY RATES IN OLDER MEN: MROS SLEEP STUDY
2010
The circadian clock: pacemaker and tumour suppressor
2003
A stress response pathway regulates DNA damage through β2-adrenoreceptors and β-arrestin-1
2011 StandoutNatureNobel
Life’s Essential 8: Updating and Enhancing the American Heart Association’s Construct of Cardiovascular Health: A Presidential Advisory From the American Heart Association
2022 Standout
Structure and Function of Animal Cryptochromes
2007 StandoutNobel
Methodological Challenges When Using Actigraphy in Research
2008
Engineering interferons and interleukins for cancer immunotherapy
2022
Molecular mechanisms of cisplatin resistance
2011 Standout
Relationship between cytochrome 3A activity, inflammatory status and the risk of docetaxel-induced febrile neutropenia: a prospective study
2006
Inflammation and tumor progression: signaling pathways and targeted intervention
2021 Standout
Systems Biology of Circadian-Immune Interactions
2012
Stress sensitivity in metastatic breast cancer: Analysis of hypothalamic–pituitary–adrenal axis function
2006
Clinical Use of Interferon‐γ
2009
Effect of walking on circadian rhythms and sleep quality of patients with lung cancer: a randomised controlled trial
2016
Broad-Spectrum Antibiotic or G-CSF as Potential Countermeasures for Impaired Control of Bacterial Infection Associated with an SPE Exposure during Spaceflight
2015 StandoutNobel
Circadian clock control of the cellular response to DNA damage
2010 StandoutNobel
Circadian control of the immune system
2013 Standout
Circadian variation inO6-alkylguanine-DNA alkyltransferase activity in circulating blood mononuclear cells of healthy human subjects
2000
2010 update of EORTC guidelines for the use of granulocyte-colony stimulating factor to reduce the incidence of chemotherapy-induced febrile neutropenia in adult patients with lymphoproliferative disorders and solid tumours
2010 Standout
Circadian Transcription Contributes to Core Period Determination in Drosophila
2008 StandoutNobel
Circadian disruption in cancer: a neuroendocrine-immune pathway from stress to disease?
2003
Exercise and well-being: a review of mental and physical health benefits associated with physical activity
2005 Standout
The Effect of Seated Exercise on Fatigue and Quality of Life in Women With Advanced Breast Cancer
2004
The Circadian Timing System: A Coordinator of Life Processes [Chronobiological Investigations]
2008
The influence of bio-behavioural factors on tumour biology: pathways and mechanisms
2006
The relationship between fatigue and sleep in cancer patients: a review
2001
How to calculate the dose of chemotherapy
2002
Cancer treatment and survivorship statistics, 2012
2012 Standout
Phase II study of weekly docetaxel in patients with metastatic breast cancer
2002
The Role of Actigraphy in the Study of Sleep and Circadian Rhythms
2003 Standout
Biochemical Analysis of the Canonical Model for the Mammalian Circadian Clock
2011 StandoutNobel
Exercise Guidelines for Cancer Survivors: Consensus Statement from International Multidisciplinary Roundtable
2019 Standout
Host Circadian Clock as a Control Point in Tumor Progression
2002
Cancer-related fatigue—mechanisms, risk factors, and treatments
2014 Standout
MASCC/ISOO clinical practice guidelines for the management of mucositis secondary to cancer therapy
2020 Standout
Evaluation of the nutritional and inflammatory status in cancer patients for the risk assessment of severe haematological toxicity following chemotherapy
2002
Cancer-related inflammation and treatment effectiveness
2014 Standout
The anti-angiogenic basis of metronomic chemotherapy
2004 Standout
Behavioural and hypothalamic molecular effects of the anti-cancer agent cisplatin in the rat: A model of chemotherapy-related malaise?
2006 StandoutNobel
If it goes up, must it come down? Chronic stress and the hypothalamic-pituitary-adrenocortical axis in humans.
2007 Standout
Immune enhancement and anti-tumour activity of IL-23
2006
Phase II Multi-Institutional Trial of the Histone Deacetylase Inhibitor Romidepsin As Monotherapy for Patients With Cutaneous T-Cell Lymphoma
2009 Standout
Circadian clock disruption improves the efficacy of chemotherapy through p73-mediated apoptosis
2011 StandoutNobel
Phase II Study of ET-743 in Advanced Soft Tissue Sarcomas: A European Organisation for the Research and Treatment of Cancer (EORTC) Soft Tissue and Bone Sarcoma Group Trial
2005 Standout
Neuroendocrine-Immune Mechanisms of Behavioral Comorbidities in Patients With Cancer
2008
American College of Sports Medicine Roundtable on Exercise Guidelines for Cancer Survivors
2010 Standout
A review of human carcinogens—Part B: biological agents
2009 Standout
ERCC1 and Thymidylate Synthase mRNA Levels Predict Survival for Colorectal Cancer Patients Receiving Combination Oxaliplatin and Fluorouracil Chemotherapy
2001
Pathogenesis ofHelicobacter pyloriInfection
2006 Standout
Regulation of apoptosis by the circadian clock through NF-κB signaling
2011 StandoutNobel
About Sleep's Role in Memory
2013 Standout
Comparative Photochemistry of Animal Type 1 and Type 4 Cryptochromes
2009 StandoutNobel
Circadian Timing in Cancer Treatments
2010
The Role of Clock Genes in Pharmacology
2010
Carcinogenicity of shift-work, painting, and fire-fighting
2007 Standout
Circadian Clock, Cancer, and Chemotherapy
2014 StandoutNobel
Effect of circadian clock mutations on DNA damage response in mammalian cells
2012 StandoutNobel
The Mammalian Circadian Timing System: Organization and Coordination of Central and Peripheral Clocks
2010 Standout
Gene-based vaccines and immunotherapeutics
2004
Phase I and Pharmacokinetic Study of Ecteinascidin-743, a New Marine Compound, Administered as a 24-hour Continuous Infusion in Patients With Solid Tumors
2001
Elevated Serum Cytokines Correlated with Altered Behavior, Serum Cortisol Rhythm, and Dampened 24-Hour Rest-Activity Patterns in Patients with Metastatic Colorectal Cancer
2005
Photopharmacology: Beyond Proof of Principle
2014 StandoutNobel
Cancer-Related Fatigue: The Scale of the Problem
2007
Low-Dose Adenovirus Vaccine Encoding Chimeric Hepatitis B Virus Surface Antigen-Human Papillomavirus Type 16 E7 Proteins Induces Enhanced E7-Specific Antibody and Cytotoxic T-Cell Responses
2005 StandoutNobel
Long-Term Follow-Up of Gastric MALT Lymphoma After Helicobacter Pylori Eradication
2005
Dose translation from animal to human studies revisited
2007 Standout
Effects of Chronic Jet Lag on Tumor Progression in Mice
2004
Works of Pascal Bleuzen being referenced
TG1042 (Adenovirus-interferon-γ) in Primary Cutaneous B-cell Lymphomas: A Phase II Clinical Trial
2014
Decreased topotecan platelet toxicity with successive topotecan treatment cycles in advanced ovarian cancer patients
1999
Phase I/II study of adenovirus-interferon-γ (TG1042) in primary cutaneous lymphomas (CL)
2004
Adenovirus-mediated intralesional interferon-γ gene transfer induces tumor regressions in cutaneous lymphomas
2004
Marked 24-h rest/activity rhythms are associated with better quality of life, better response, and longer survival in patients with metastatic colorectal cancer and good performance status.
2000
Factors predicting for efficacy of oxaliplatin in combination with 5-fluorouracil (5-FU)±folinic acid (FA) in a compassionate-use cohort of 370 5-FU-resistant advanced colorectal cancer (CRC) patients
2000
Factors Predicting for Efficacy and Safety of Docetaxel in a Compassionate-Use Cohort of 825 Heavily Pretreated Advanced Breast Cancer Patients
2000